Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Johnson and Johnson
Harvard Business School
Mallinckrodt
Moodys

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sildenafil Citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00057759 ↗ Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer Completed National Cancer Institute (NCI) N/A 2003-01-01 RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910.
NCT00057759 ↗ Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer Completed Radiation Therapy Oncology Group N/A 2003-01-01 RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910.
NCT00080808 ↗ Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer Completed National Cancer Institute (NCI) Phase 2 2001-08-01 RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer.
NCT00080808 ↗ Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer Completed M.D. Anderson Cancer Center Phase 2 2001-08-01 RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sildenafil Citrate

Condition Name

Condition Name for Sildenafil Citrate
Intervention Trials
Erectile Dysfunction 18
Impotence 12
Pulmonary Arterial Hypertension 10
Pulmonary Hypertension 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sildenafil Citrate
Intervention Trials
Erectile Dysfunction 33
Hypertension 27
Hypertension, Pulmonary 16
Pulmonary Arterial Hypertension 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sildenafil Citrate

Trials by Country

Trials by Country for Sildenafil Citrate
Location Trials
United States 207
United Kingdom 37
Mexico 21
Spain 20
Canada 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sildenafil Citrate
Location Trials
Texas 15
California 14
New York 12
Massachusetts 11
North Carolina 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sildenafil Citrate

Clinical Trial Phase

Clinical Trial Phase for Sildenafil Citrate
Clinical Trial Phase Trials
Phase 4 38
Phase 3 24
Phase 2/Phase 3 5
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sildenafil Citrate
Clinical Trial Phase Trials
Completed 78
Unknown status 18
Terminated 12
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sildenafil Citrate

Sponsor Name

Sponsor Name for Sildenafil Citrate
Sponsor Trials
Pfizer 45
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 32
Ain Shams University 8
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sildenafil Citrate
Sponsor Trials
Other 112
Industry 91
NIH 8
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Colorcon
Moodys
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.